<DOC>
	<DOCNO>NCT02971995</DOCNO>
	<brief_summary>Prostate cancer first cancer human ( 25 % ) . The widely use tracer oncology , 18-Fluoro DeoxyGlucose allow study prostatic neoplasia . On hand , Choline , amino alcohol , involve synthesis cell membrane affinity prostate cell . Its concentration directly proportional cell proliferation . The analogue choline advantage rapid stable accumulation time cancer cell , rapid urinary excretion ( 4 minute injection ) . The goal study assess feasibility accuracy target image guide prostate biopsy detect prostate cancer Imaging fusion choline-PET/CT compare 1.5T multiparametric magnetic resonance imaging ( mpMRI ) 3D-transrectal ultrasound ( TRUS ) .</brief_summary>
	<brief_title>Trimodal ( 18 ) F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Patients suspicion prostate cancer Patients perform prostate mpMRI FCholine 18 PET scan Patient capable receive clear information Patient give write consent participation via consent sign parent patient ( legal tutor ) Patient cover healthcare insurance Patients without suspect image neoplasia mpMRI FCholine 18 PET scan</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>